Niagen Bioscience (NAGE) Stock Chart & Stock Price History $11.50 +0.42 (+3.79%) As of 04:00 PM Eastern Add Compare Share Share Chart Stock AnalysisAnalyst ForecastsChartCompetitorsEarningsHeadlinesInsider TradesOwnershipSEC FilingsShort InterestTrendsBuy This Stock Niagen Bioscience Stock Price Performance The Niagen Bioscience (NAGE) stock chart highlights key performance trends across multiple timeframes. Since the beginning of the year, the stock increased 116.78%. In the past month, the stock has decreased 18.67%, reflecting recent market activity. As of the latest close, Niagen Bioscience traded at $11.08 with a market cap of $872.77 million and volume of 1.02 million shares. Receive NAGE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Niagen Bioscience and its competitors with MarketBeat's FREE daily newsletter. Email Address 5 Day Performance+1.77%1 Month Performance-18.67%3 Month Performance+75.84%Year-To-Date Performance+116.78% NAGE Stock Chart for Wednesday, July, 16, 2025 NAGE Chart by TradingView Niagen Bioscience Stock Price History Daily Weekly Monthly Yearly Time Frame Custom Range 1 Month 3 Months 6 Months Year-to-Date 1 Year 3 Year 5 Year Time Frame Start Date End Date Export to Excel DateOpening PriceClosing PriceHighLowVolumeMarket Capitalization07/15/2025$11.26$11.08-1.60%$11.38$10.971.02 million shs$872.77 million07/14/2025$11.30$11.26-0.35%$11.34$11.05754,318 shs$886.95 million07/11/2025$11.79$11.30-4.16%$11.90$11.28925,501 shs$890.10 million07/10/2025$12.12$11.79-2.72%$12.19$11.611.24 million shs$928.70 million07/09/2025$11.97$12.12+1.25%$12.41$11.97958,859 shs$954.69 million07/08/2025$12.44$11.97-3.78%$12.56$11.941.33 million shs$942.88 million07/07/2025$12.71$12.44-2.12%$12.65$12.161.18 million shs$979.90 million07/04/2025$12.71$12.71$12.74$12.16727,210 shs$1.00 billion07/03/2025$12.58$12.71+1.03%$12.74$12.16727,210 shs$1.00 billion07/02/2025$12.81$12.58-1.80%$13.09$12.551.00 million shs$990.93 million Get the Latest News and Ratings for NAGE and Related StocksEnter your email address below to receive the latest news and analysts' ratings for Niagen Bioscience and its competitors with MarketBeat's FREE daily newsletter. 07/01/2025$14.41$12.81-11.10%$14.40$12.641.76 million shs$1.01 billion06/30/2025$14.22$14.41+1.34%$14.69$13.951.25 million shs$1.14 billion06/27/2025$13.82$14.22+2.89%$14.26$13.352.46 million shs$1.12 billion06/26/2025$13.41$13.82+3.06%$13.88$13.21856,298 shs$1.09 billion06/25/2025$14.13$13.41-5.10%$14.33$13.40743,934 shs$1.06 billion06/24/2025$13.64$14.13+3.59%$14.22$13.61854,274 shs$1.11 billion06/23/2025$13.44$13.64+1.49%$13.65$13.08727,145 shs$1.07 billion06/20/2025$13.78$13.44-2.47%$13.96$13.34956,657 shs$1.06 billion06/19/2025$13.78$13.78$14.14$13.31822,417 shs$1.09 billion06/18/2025$13.88$13.78-0.72%$14.14$13.31822,417 shs$1.09 billion06/17/2025$14.14$13.88-1.84%$14.15$13.74707,549 shs$1.09 billion06/16/2025$13.63$14.14+3.74%$14.45$13.80785,152 shs$1.11 billion Related Companies VKTX Stock Chart SWTX Stock Chart PTGX Stock Chart AAPG Stock Chart MLTX Stock Chart IMVT Stock Chart HCM Stock Chart CRNX Stock Chart KYMR Stock Chart MOR Stock Chart Receive NAGE Stock News and Ratings via EmailSign-up to receive the latest news and ratings for Niagen Bioscience and its competitors with MarketBeat's FREE daily newsletter. This page (NASDAQ:NAGE) was last updated on 7/16/2025 by MarketBeat.com Staff From Our PartnersElon’s Secret Social Security BombshellTo All Americans Born Before April 16th, 1963: Did Trump Just Give The Green Light To Radically RE-DO Social S...Banyan Hill Publishing | SponsoredMarket Panic: Trump Just Dropped a Bomb on Your Stockstock Market Panic: Trump Just Dropped a Bomb on Your Stocks The market is in freefall—and Trump's new tarif...American Alternative | SponsoredINVESTOR ALERT: Tiny “$3 AI Wonder Stock” on the Verge of Blasting OffRight now, we’re witnessing a monumental shift in the world.Traders Agency | Sponsored"Death Spiral" Threatening Your SavingsThe "Death Spiral" Threatening Your Savings But this time, it's not just Dalio ringing the alarm bells…GoldCo Precious Metals | SponsoredEveryone’s watching Nvidia right now. Here’s why I’m excited.So, unless you’ve been living under a rock, you probably saw the news… Nvidia just signed a $7 BILLION deal...Timothy Sykes | SponsoredThe Trump Dump is starting; Get out of stocks now?The first 365 days of the Trump presidency… Will be the best time to get rich in American history.Paradigm Press | SponsoredSpecial gold investment soars 2,300% ... 5,090% ... 9,850%In my 54 years as an investor, I’ve seen my share of gold bull markets. But nothing comes close to the rall...Weiss Ratings | SponsoredPost-Halving = Profit Season (Here’s How to Win It)It happens like clockwork. Every four years, the crypto market enters a new phase — and for those who know how...Crypto Swap Profits | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Niagen Bioscience, Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Niagen Bioscience With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
